Skip to main content
OpenTrials

Clinical trial condition

Receptor Tyrosine Kinase (KIT) Mutated Melanoma

Explore clinical trials studying Receptor Tyrosine Kinase (KIT) Mutated Melanoma. Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies
Refine in advanced search Browse all conditions

Receptor Tyrosine Kinase (KIT) Mutated Melanoma trial results

Completed

Study to Allow Access to Nilotinib for Patients Who Are on Nilotinib Treatment in a Novartis-sponsored Study

NCT01735955

Conditions
Acute Lymphoblastic Leukemia (ALL), Albinism, Amino Acid Metabolism, Inborn Errors, +41 more
Locations
  • Novartis Investigative Site Albany, New York, United States
  • Novartis Investigative Site Houston, Texas, United States
  • Novartis Investigative Site Vienna, Austria
  • Novartis Investigative Site Vancouver, British Columbia, Canada
View all 33 locations
View Trial Details

Related conditions